E
NovAccess Global Inc. XSNX
$0.0003 -$0.0001-25.00% OTC PK
Recommendation
Prev Close
$0.0003
Volume
181
Avg Vol (90D)
3,467
Market Cap
$18.57K
Dividend & Yield
--
52-Week Range
$0.0002 - $0.019
P/E (TTM)
--
EPS (TTM)
-$0.1107
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$1.22M
Net Income (TTM)
-$1.94M
Balance Sheet
Total Assets (Q)
$273.60K
Total Debt (Q)
$2.28M
Total Liabilities (Q)
$7.70M
Book Value Per Share (Q)
-$0.1966
Cash Flow
Cash from Operations (TTM)
-$314.90K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$254.20K
Net Change in Cash (TTM)
-$60.60K
Filings
Filing Date
Thursday, October 31, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
0.71
7-Day Total Return
0.00%
30-Day Total Return
50.00%
60-Day Total Return
0.00%
90-Day Total Return
-94.23%
Year to Date Total Return
-76.92%
1-Year Total Return
-95.71%
2-Year Total Return
-99.79%
3-Year Total Return
-99.89%
5-Year Total Return
-99.88%
52-week Low
Jan 07, 2025 - $0.0002
52-week High
Sep 11, 2024 - $0.019
Valuation
Market Cap
$18.57K - Nano Cap
Enterprise Value
$7.04M
Price/Sales (TTM)
--
Price/Book (Q)
0.00
Dividends and Shares
Shares Outstanding
54.12M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.novaccessglobal.com
Phone Number
213 642 9268
Address
8584, Washington Street
Chagrin Falls, OH 44023
Country
United States
Year Founded
1997
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing... more
OTC PK 04/28/2025 11:02AM Eastern Quotes delayed